SMA
IBER.U
Sage Mountain Advisors’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,200
| Closed | -$132K | – | 384 |
|
|
2022
Q4 | $132K | Sell |
13,200
-820
| -6% | -$8.18K | 0.03% | 183 |
|
|
2022
Q3 | $139K | Sell |
14,020
-64,910
| -82% | -$644K | 0.04% | 208 |
|
|
2022
Q2 | $774K | Sell |
78,930
-2,130
| -3% | -$20.9K | 0.14% | 127 |
|
|
2022
Q1 | $794K | Sell |
81,060
-8,120
| -9% | -$79.5K | 0.12% | 155 |
|
|
2021
Q4 | $894K | Sell |
89,180
-1,920
| -2% | -$19.2K | 0.11% | 165 |
|
|
2021
Q3 | $911K | Sell |
91,100
-2,370
| -3% | -$23.7K | 0.13% | 140 |
|
|
2021
Q2 | $939K | Hold |
93,470
| – | – | 0.16% | 126 |
|
|
2021
Q1 | $922K | Buy |
+93,470
| New | +$922K | 0.2% | 86 |
|